Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Rare Tumours 1

Interventions

Radiotherapy 2Psychiatric Rehabilitation 2Hydroxyurea 2lutetium Lu 177 dotatate 1emvododstat 1Sunitinib 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Proton Therapy 1Octreotide 1Observation 1Mifepristone 1Ifosfamide 1Everolimus 1Chemotherapy, Adjuvant 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Meningioma × Sunitinib × Clear all
NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting
136 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡